Bio-Imaging Lab, University of Antwerp, Universiteitsplein 1, Wilrijk, Antwerp 2610, Belgium.
Bio-Imaging Lab, University of Antwerp, Universiteitsplein 1, Wilrijk, Antwerp 2610, Belgium.
Neurobiol Dis. 2019 Apr;124:93-107. doi: 10.1016/j.nbd.2018.11.010. Epub 2018 Nov 13.
The development and characterization of new improved animal models is pivotal in Alzheimer's Disease (AD) research, since valid models enable the identification of early pathological processes, which are often not accessible in patients, as well as subsequent target discovery and evaluation. The TgF344-AD rat model of AD, bearing mutant human amyloid precursor protein (APPswe) and Presenilin 1 (PSEN1ΔE9) genes, has been described to manifest the full spectrum of AD pathology similar to human AD, i.e. progressive cerebral amyloidosis, tauopathy, neuronal loss and age-dependent cognitive decline. Here, AD-related pathology in female TgF344-AD rats was examined longitudinally between 6 and 18 months by means of complementary translational MRI techniques: resting state functional MRI (rsfMRI) to evaluate functional connectivity (FC) and diffusion tensor imaging (DTI) to assess the microstructural integrity. Additionally, an evaluation of macroscopic changes (3D anatomical MRI) and an image-guided validation of ex vivo pathology were performed. We identified slightly decreased FC at 6 months followed by severe and widespread hypoconnectivity at 10 months of age as the earliest detectable pathological MRI hallmark. This initial effect was followed by age-dependent progressive microstructural deficits in parallel with age-dependent ex vivo AD pathology, without signs of macroscopic alterations such as hippocampal atrophy. This longitudinal MRI study in the TgF344-AD rat model of AD revealed early rsfMRI and DTI abnormalities as seen in human AD patients. The characterization of AD pathology in this rat model using non-invasive MRI techniques further highlights the translational value of this model, as well as its use for potential treatment evaluation.
新型改良动物模型的开发和特征描述是阿尔茨海默病(AD)研究的关键,因为有效的模型能够识别早期的病理过程,而这些过程在患者中往往无法观察到,同时也能够发现后续的靶标并进行评估。TgF344-AD 大鼠 AD 模型携带突变型人类淀粉样前体蛋白(APPswe)和早老素 1(PSEN1ΔE9)基因,被描述为表现出与人类 AD 相似的 AD 全谱病理,即进行性脑淀粉样变性、tau 病、神经元丧失和与年龄相关的认知能力下降。在这里,通过互补的转化 MRI 技术,在 6 至 18 个月的时间内对雌性 TgF344-AD 大鼠的 AD 相关病理进行了纵向研究:静息状态功能 MRI(rsfMRI)用于评估功能连接(FC),扩散张量成像(DTI)用于评估微观结构完整性。此外,还进行了宏观变化(3D 解剖 MRI)的评估和离体病理学的图像引导验证。我们发现,6 个月时的 FC 略有下降,随后在 10 个月时出现严重且广泛的低连接,这是最早可检测到的病理 MRI 特征。这种初始效应随后是与年龄相关的微观结构缺陷的进行性进展,与体外 AD 病理学的进行性发展平行,没有海马萎缩等宏观变化的迹象。这项在 TgF344-AD AD 大鼠模型中的纵向 MRI 研究揭示了人类 AD 患者中可见的早期 rsfMRI 和 DTI 异常。使用非侵入性 MRI 技术对该大鼠模型中的 AD 病理学进行特征描述,进一步凸显了该模型的转化价值,以及其在潜在治疗评估中的应用。